Update on corneal collagen crosslinking for ectasia.

Area of Science:

• Ophthalmology
• Biomedical Engineering

Background:

• Corneal collagen crosslinking (CXL) is a standard treatment for stabilizing corneal ectatic disorders like keratoconus.
• Established CXL protocols have demonstrated significant benefits in preventing disease progression.

Purpose of the Study:

• To review recent advancements in CXL protocols.
• To explore modifications aimed at enhancing corneal stability and reducing procedure time.
• To assess the safety and efficacy of novel CXL techniques.

Main Methods:

• Review of current literature on accelerated and transepithelial CXL protocols.
• Analysis of research focusing on pulsed CXL and its impact on efficacy.
• Evaluation of transepithelial CXL in reducing postoperative pain and infection risk.

Main Results:

• Accelerated CXL protocols show promise in shortening treatment duration while maintaining efficacy.
• Pulsed CXL may enhance the long-term stability achieved with accelerated methods.
• Transepithelial CXL offers potential benefits in reducing patient discomfort and complication rates.

Conclusions:

• Newer CXL protocols are being developed to improve safety and effectiveness.
• While current research is promising, long-term studies are crucial to validate the sustained efficacy of these modified protocols.
• Further investigation is needed to fully understand the long-term impact of novel CXL techniques on corneal stability.